MedPath

Comparison of therapeutic effects of long-acting calcium channel blockers on coronary vasospasm.; Open label randomized trial (ATTACK VSA TRIAL)

Not Applicable
Conditions
Vasospastic Angina Pectoris
Registration Number
JPRN-UMIN000001105
Lead Sponsor
The Cardiovascular Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. patients who have organic coronary narrowing only but don't have coronary vasospasm 2. patient with acute myocardial infarction (within one month) 3. diabetes mellitus patients with poorly-controlled glycemia 4. severe hypertensive patients(>=180/>=110mmHg) 5. patients who is not able to administrate dihydropyridine calcium channel blockers 6. Patients who is not allowed to enroll the trial by doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath